協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/16 | 2,772 | 2,881 | 2,757 | 2,869 | +144 | +5.3% | 1,031,600 |
2020/06/15 | 2,740 | 2,822 | 2,722 | 2,725 | -55 | -2% | 697,900 |
2020/06/12 | 2,720 | 2,793 | 2,673 | 2,780 | +2 | +0.1% | 1,603,900 |
2020/06/11 | 2,808 | 2,816 | 2,769 | 2,778 | -51 | -1.8% | 1,464,400 |
2020/06/10 | 2,785 | 2,840 | 2,775 | 2,829 | +8 | +0.3% | 1,331,100 |
2020/06/09 | 2,822 | 2,834 | 2,805 | 2,821 | -30 | -1.1% | 1,300,600 |
2020/06/08 | 2,914 | 2,925 | 2,836 | 2,851 | -59 | -2% | 1,398,200 |
2020/06/05 | 2,962 | 2,969 | 2,889 | 2,910 | -53 | -1.8% | 1,236,800 |
2020/06/04 | 2,937 | 2,979 | 2,911 | 2,963 | +12 | +0.4% | 1,171,700 |
2020/06/03 | 3,010 | 3,025 | 2,936 | 2,951 | -23 | -0.8% | 1,045,300 |
2020/06/02 | 2,887 | 2,985 | 2,868 | 2,974 | +112 | +3.9% | 1,355,600 |
2020/06/01 | 2,900 | 2,901 | 2,850 | 2,862 | -60 | -2.1% | 1,429,100 |
2020/05/29 | 2,930 | 2,954 | 2,875 | 2,922 | +37 | +1.3% | 3,695,900 |
2020/05/28 | 2,861 | 2,885 | 2,808 | 2,885 | +46 | +1.6% | 1,027,000 |
2020/05/27 | 2,800 | 2,869 | 2,781 | 2,839 | +36 | +1.3% | 1,038,700 |
2020/05/26 | 2,798 | 2,851 | 2,790 | 2,803 | +29 | +1% | 1,172,800 |
2020/05/25 | 2,767 | 2,779 | 2,746 | 2,774 | +54 | +2% | 684,200 |
2020/05/22 | 2,701 | 2,733 | 2,680 | 2,720 | +29 | +1.1% | 962,700 |
2020/05/21 | 2,673 | 2,707 | 2,650 | 2,691 | +27 | +1% | 902,900 |
2020/05/20 | 2,621 | 2,676 | 2,605 | 2,664 | +43 | +1.6% | 723,000 |
2020/05/19 | 2,647 | 2,654 | 2,618 | 2,621 | -3 | -0.1% | 846,100 |
2020/05/18 | 2,607 | 2,640 | 2,602 | 2,624 | +41 | +1.6% | 627,600 |
2020/05/15 | 2,607 | 2,610 | 2,547 | 2,583 | +12 | +0.5% | 786,800 |
2020/05/14 | 2,618 | 2,636 | 2,565 | 2,571 | -44 | -1.7% | 724,500 |
2020/05/13 | 2,636 | 2,655 | 2,611 | 2,615 | +15 | +0.6% | 998,800 |
2020/05/12 | 2,587 | 2,621 | 2,563 | 2,600 | +18 | +0.7% | 665,200 |
2020/05/11 | 2,616 | 2,653 | 2,580 | 2,582 | -32 | -1.2% | 937,700 |
2020/05/08 | 2,640 | 2,650 | 2,599 | 2,614 | +46 | +1.8% | 1,892,600 |
2020/05/07 | 2,517 | 2,584 | 2,462 | 2,568 | +99 | +4% | 1,551,000 |
2020/05/01 | 2,511 | 2,530 | 2,431 | 2,469 | -49 | -1.9% | 1,493,000 |
2020/04/30 | 2,514 | 2,535 | 2,476 | 2,518 | +64 | +2.6% | 1,435,100 |
2020/04/28 | 2,447 | 2,468 | 2,425 | 2,454 | +8 | +0.3% | 779,900 |
2020/04/27 | 2,458 | 2,461 | 2,422 | 2,446 | +5 | +0.2% | 841,100 |
2020/04/24 | 2,460 | 2,470 | 2,430 | 2,441 | +6 | +0.2% | 858,400 |
2020/04/23 | 2,420 | 2,446 | 2,409 | 2,435 | +17 | +0.7% | 742,200 |
2020/04/22 | 2,339 | 2,418 | 2,331 | 2,418 | +59 | +2.5% | 1,084,300 |
2020/04/21 | 2,380 | 2,397 | 2,350 | 2,359 | -20 | -0.8% | 708,200 |
2020/04/20 | 2,371 | 2,393 | 2,363 | 2,379 | -62 | -2.5% | 791,800 |
2020/04/17 | 2,433 | 2,452 | 2,403 | 2,441 | +51 | +2.1% | 823,400 |
2020/04/16 | 2,424 | 2,443 | 2,386 | 2,390 | -62 | -2.5% | 891,700 |
2020/04/15 | 2,490 | 2,493 | 2,425 | 2,452 | +12 | +0.5% | 1,066,200 |
2020/04/14 | 2,447 | 2,467 | 2,411 | 2,440 | +9 | +0.4% | 647,500 |
2020/04/13 | 2,431 | 2,460 | 2,420 | 2,431 | -32 | -1.3% | 552,600 |
2020/04/10 | 2,452 | 2,463 | 2,411 | 2,463 | +47 | +1.9% | 1,030,100 |
2020/04/09 | 2,396 | 2,416 | 2,363 | 2,416 | +13 | +0.5% | 768,200 |
2020/04/08 | 2,375 | 2,417 | 2,341 | 2,403 | +28 | +1.2% | 1,273,100 |
2020/04/07 | 2,435 | 2,456 | 2,309 | 2,375 | +28 | +1.2% | 1,012,400 |
2020/04/06 | 2,300 | 2,394 | 2,299 | 2,347 | +65 | +2.8% | 1,058,200 |
2020/04/03 | 2,287 | 2,377 | 2,256 | 2,282 | -37 | -1.6% | 1,103,700 |
2020/04/02 | 2,273 | 2,335 | 2,262 | 2,319 | +24 | +1% | 1,332,600 |
1201~
1250
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 216,000円 | -3.5% | -11.3% | 2.78% | 19.84倍 | 1.33倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 134,400円 | +0.9% | +380.2% | 5.80% | 18.51倍 | 1.59倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 218,200円 | +20.9% | +10.6% | 3.02% | 10.31倍 | 1.36倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 387,200円 | +1.7% | -2.9% | 4.13% | 25.40倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 148,800円 | +0.6% | +43.3% | 5.38% | 10.43倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム